• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by LivaNova PLC

    5/29/25 4:05:39 PM ET
    $LIVN
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $LIVN alert in real time by email
    SD 1 a2024conflictmineralsrepor.htm SD Document

    As filed with the Securities and Exchange Commission on May 29, 2025

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM SD
    Specialized Disclosure Report

    image_0a.jpg
    LivaNova PLC



    England and Wales
    (State or other jurisdiction of incorporation or organization)
    001-37599
    (Commission File Number)
    98-1268150
    (I.R.S. Employer Identification)

    20 Eastbourne Terrace London, United Kingdom W2 6LG
    (Address of Principal Executive Offices) (Zip Code)

    Michael Hutchinson Company Secretary
    + 44 (0) 203 325 0665

    (Name and telephone number, including area code, of the person to contact in connection with this report) Check the appropriate box to indicate the rule pursuant to which this form is being filed:
    ☒    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.

    □Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended.



    Section 1 Conflict Minerals Disclosure

    Item 1.01 Conflict Minerals Disclosure and Report

    LivaNova PLC (collectively with its subsidiaries, the “Company” or “LivaNova”) is filing this Specialized Disclosure report on Form SD (this “Form SD”) for LivaNova’s supply chain operations for the year ended December 31, 2024. This Form SD is presented in compliance with Rule 13p-1 under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, 2024 to December 31, 2024.

    A copy of LivaNova’s Conflict Minerals Report is filed as a part of this Form SD. A copy of this Form SD may also be found on the Company’s website at https://investor.livanova.com/financial-information/sec-filings.

    Item 1.02 Exhibits

    LivaNova has filed as an exhibit to this Form SD, the Conflict Minerals Report required by Item 1.01.


    Section 2 Resource Extraction Issuer Disclosure

    Item 2.01 Resource Extraction Issuer Disclosure and Report

    Not applicable.


    Section 3 Exhibits

    Item 3.01 Exhibits

    The following exhibit is filed as part of this report.


    ExhibitDescription
    1.01
    Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD.










    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    LivaNova PLC
    Date: May 29, 2025
    By: /s/ Michael Hutchinson
    Name: Michael Hutchinson
    Title: SVP, Company Secretary & Chief Legal Officer

    Get the next $LIVN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LIVN

    DatePrice TargetRatingAnalyst
    5/20/2025$60.00Peer Perform → Outperform
    Wolfe Research
    2/26/2025Outperform → Peer Perform
    Wolfe Research
    10/4/2024$65.00Buy
    Goldman
    9/17/2024$55.00 → $66.00Neutral → Outperform
    Robert W. Baird
    3/20/2024Buy
    Needham
    2/20/2024$60.00 → $70.00Neutral → Buy
    Mizuho
    9/6/2023$52.00Hold
    HSBC Securities
    7/19/2023$56.00Neutral
    Robert W. Baird
    More analyst ratings